UK Markets close in 1 hr 33 mins

Orphazyme A/S (ORPHA.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
1.6050-0.0970 (-5.70%)
At close: 04:59PM CEST
Currency in DKK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3109.1000
52-week low 31.1000
50-day moving average 33.6005
200-day moving average 317.3435

Share statistics

Avg vol (3-month) 3260.52k
Avg vol (10-day) 3203.37k
Shares outstanding 534.95M
Implied shares outstanding 6N/A
Float 828.33M
% held by insiders 11.42%
% held by institutions 120.48%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Jun 2021


Profit margin 0.00%
Operating margin (ttm)-5,922.12%

Management effectiveness

Return on assets (ttm)-88.16%
Return on equity (ttm)-251.34%

Income statement

Revenue (ttm)13.15M
Revenue per share (ttm)0.40
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -762.23M
Net income avi to common (ttm)-845.61M
Diluted EPS (ttm)-25.5510
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)334.18M
Total cash per share (mrq)9.56
Total debt (mrq)58.59M
Total debt/equity (mrq)35.13
Current ratio (mrq)1.80
Book value per share (mrq)4.77

Cash flow statement

Operating cash flow (ttm)-716.63M
Levered free cash flow (ttm)-392.38M